Enanta Pharmaceuticals (ENTA) Capital Expenditures (2012 - 2026)
Enanta Pharmaceuticals posted quarterly Capital Expenditures of $15000.0 for Q1 2026, down 99.41% year-on-year from $2.5 million in Q1 2025, and down 89.51% on a QoQ basis from $143000.0 in Q4 2025.
Enanta Pharmaceuticals (ENTA) has 15 years of Capital Expenditures data on file, last reported at $15000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures fell 99.41% year-over-year to $15000.0; the trailing twelve-month figure through Mar 2026 stood at $1.8 million (down 93.39% YoY), and the FY2025 full-year result was $12.9 million, down 28.15% from the prior year.
- Capital Expenditures for Q1 2026 stood at $15000.0, down from $143000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $11.5 million in Q3 2024 and bottomed at -$9.9 million in Q2 2025.
- The 5-year median for Capital Expenditures is $1.7 million (2024), against an average of $2.4 million.
- The widest annual swing landed in 2022, when Capital Expenditures surged 6760.87%; it then plunged 349.61% in 2025.
- A 5-year view of Capital Expenditures shows it stood at $3.2 million in 2022, then sank by 75.06% to $787000.0 in 2023, then surged by 1011.18% to $8.7 million in 2024, then slumped by 98.36% to $143000.0 in 2025, then tumbled by 89.51% to $15000.0 in 2026.
- The last three Capital Expenditures figures came in at $15000.0 (Q1 2026), $143000.0 (Q4 2025), and $11.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 230.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15,000.00 |
| Mar 31, 2026 | 15,000.00 |
| Dec 31, 2025 | 143,000.00 |
| Dec 31, 2025 | 143,000.00 |
| Sep 30, 2025 | 11.50 Mn |
| Sep 30, 2025 | 11.50 Mn |
| Jun 30, 2025 | -9.89 Mn |
| Jun 30, 2025 | -9.89 Mn |
| Mar 31, 2025 | 2.54 Mn |
| Mar 31, 2025 | 2.54 Mn |
| Dec 31, 2024 | 8.75 Mn |
| Dec 31, 2024 | 8.75 Mn |
| Sep 30, 2024 | 11.53 Mn |
| Sep 30, 2024 | 11.53 Mn |
| Jun 30, 2024 | 3.96 Mn |
| Jun 30, 2024 | 3.96 Mn |
| Mar 31, 2024 | 1.67 Mn |
| Mar 31, 2024 | 1.67 Mn |
| Dec 31, 2023 | 787,000.00 |
| Dec 31, 2023 | 787,000.00 |
| Sep 30, 2023 | 1.37 Mn |
| Sep 30, 2023 | 1.37 Mn |
| Jun 30, 2023 | 2.15 Mn |
| Jun 30, 2023 | 2.15 Mn |
| Mar 31, 2023 | 2.38 Mn |
| Mar 31, 2023 | 2.38 Mn |
| Dec 31, 2022 | 3.16 Mn |
| Dec 31, 2022 | 3.16 Mn |
| Sep 30, 2022 | 527,000.00 |
| Sep 30, 2022 | 527,000.00 |
| Jun 30, 2022 | 251,000.00 |
| Jun 30, 2022 | 251,000.00 |
| Mar 31, 2022 | 391,000.00 |
| Mar 31, 2022 | 391,000.00 |
| Dec 31, 2021 | 46,000.00 |
| Dec 31, 2021 | 46,000.00 |
| Sep 30, 2021 | 734,000.00 |
| Sep 30, 2021 | 734,000.00 |
| Jun 30, 2021 | -302,000.00 |
| Jun 30, 2021 | -302,000.00 |
| Mar 31, 2021 | 130,000.00 |
| Mar 31, 2021 | 130,000.00 |
| Dec 31, 2020 | 188,000.00 |
| Dec 31, 2020 | 188,000.00 |
| Sep 30, 2020 | -111,000.00 |
| Sep 30, 2020 | -111,000.00 |
| Jun 30, 2020 | 190,000.00 |
| Jun 30, 2020 | 190,000.00 |
| Mar 31, 2020 | -379,000.00 |
| Mar 31, 2020 | -379,000.00 |
| Dec 31, 2019 | 488,000.00 |
| Dec 31, 2019 | 488,000.00 |
| Sep 30, 2019 | 296,000.00 |
| Sep 30, 2019 | 296,000.00 |
| Jun 30, 2019 | 2.23 Mn |
| Jun 30, 2019 | 2.23 Mn |
| Mar 31, 2019 | 1.59 Mn |
| Mar 31, 2019 | 1.59 Mn |
| Dec 31, 2018 | 1.30 Mn |
| Dec 31, 2018 | 1.30 Mn |
| Sep 30, 2018 | 43,000.00 |
| Sep 30, 2018 | 43,000.00 |
| Jun 30, 2018 | -1.19 Mn |
| Jun 30, 2018 | -1.19 Mn |
| Mar 31, 2018 | 1.15 Mn |
| Mar 31, 2018 | 1.15 Mn |
| Dec 31, 2017 | 111,000.00 |
| Dec 31, 2017 | 111,000.00 |
| Sep 30, 2017 | 234,000.00 |
| Sep 30, 2017 | 234,000.00 |
| Jun 30, 2017 | 741,000.00 |
| Jun 30, 2017 | 741,000.00 |
| Mar 31, 2017 | 578,000.00 |
| Mar 31, 2017 | 578,000.00 |
| Dec 31, 2016 | 953,000.00 |
| Dec 31, 2016 | 953,000.00 |
| Sep 30, 2016 | -3.69 Mn |
| Sep 30, 2016 | -3.69 Mn |
| Jun 30, 2016 | 613,000.00 |
| Jun 30, 2016 | 613,000.00 |
| Mar 31, 2016 | 1.51 Mn |
| Mar 31, 2016 | 1.51 Mn |
| Dec 31, 2015 | 2.20 Mn |
| Dec 31, 2015 | 2.20 Mn |
| Sep 30, 2015 | 1.58 Mn |
| Sep 30, 2015 | 1.58 Mn |
| Jun 30, 2015 | 400,000.00 |
| Jun 30, 2015 | 400,000.00 |
| Mar 31, 2015 | 100,000.00 |
| Mar 31, 2015 | 100,000.00 |
| Dec 31, 2014 | 256,000.00 |
| Dec 31, 2014 | 256,000.00 |
| Sep 30, 2014 | 485,000.00 |
| Sep 30, 2014 | 485,000.00 |
| Jun 30, 2014 | 378,000.00 |
| Jun 30, 2014 | 378,000.00 |
| Mar 31, 2014 | 141,000.00 |
| Mar 31, 2014 | 141,000.00 |
| Dec 31, 2013 | 24,000.00 |
| Dec 31, 2013 | 24,000.00 |
| Sep 30, 2013 | 202,000.00 |
| Sep 30, 2013 | 202,000.00 |
| Jun 30, 2013 | 52,000.00 |
| Jun 30, 2013 | 52,000.00 |
| Mar 31, 2013 | 341,000.00 |
| Mar 31, 2013 | 341,000.00 |
| Dec 31, 2012 | 11,000.00 |
| Dec 31, 2012 | 11,000.00 |
| Sep 30, 2012 | 111,000.00 |
| Sep 30, 2012 | 111,000.00 |
| Jun 30, 2012 | 47,000.00 |
| Jun 30, 2012 | 47,000.00 |